MARX Biotech Co (ROCO:7731) Beginning Cash Position: NT$32.8 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7731 MARX Biotech Co Ltd ROCO:7731
38 GF Score
Price NT$4.41
GF Value NT$5.48
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is MARX Biotech Co Beginning Cash Position?

MARX Biotech Co ROCO:7731 -1.34% 38 Beginning Cash Position is NT$32.8 Mil as of Jun. 2026. GuruFocus rates ROCO:7731 with a GF Score™ of 38/100 and a GF Value™ of NT$5.48 (Modestly Undervalued). The stock has 5 warning signs investors should review.

MARX Biotech Co's Beginning Cash Position for the quarter that ended in Jun. 2026 was NT$32.8 Mil.

MARX Biotech Co's quarterly Beginning Cash Position declined from Jun. 2025 (NT$74.7 Mil) to Dec. 2025 (NT$22.5 Mil) but then increased from Dec. 2025 (NT$22.5 Mil) to Jun. 2026 (NT$32.8 Mil).

MARX Biotech Co's annual Beginning Cash Position increased from Dec. 2023 (NT$27.7 Mil) to Dec. 2024 (NT$152.8 Mil) but then declined from Dec. 2024 (NT$152.8 Mil) to Dec. 2025 (NT$74.7 Mil).

MARX Biotech Co Beginning Cash Position Related Terms

MARX Biotech Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for MARX Biotech Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MARX Biotech Co Beginning Cash Position Chart

MARX Biotech Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 3.40 16.13 27.73 152.83 74.67

MARX Biotech Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 152.83 94.46 74.67 22.46 32.77
ROCO:7731
38GF Score
MARX Biotech Co Ltd ROCO:7731
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MARX Biotech Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of NT$32.8 Mil mean?
MARX Biotech Co (ROCO:7731) has a Beginning Cash Position of NT$32.8 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on MARX Biotech Co and its competitors.
Is MARX Biotech Co's Beginning Cash Position too high?
MARX Biotech Co's current Beginning Cash Position is NT$32.8 Mil. Overall, MARX Biotech Co has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's Beginning Cash Position compare to competitors?
MARX Biotech Co's Beginning Cash Position of NT$32.8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Healthcare Providers & Services company?
A good Beginning Cash Position depends on the Healthcare Providers & Services industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on MARX Biotech Co and its competitors. MARX Biotech Co's current Beginning Cash Position is NT$32.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, MARX Biotech Co (ROCO:7731) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$5.48, compared to a current price of NT$4.41 — trading 19.5% below its estimated fair value. The current Beginning Cash Position is NT$32.8 Mil. MARX Biotech Co's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current Beginning Cash Position is NT$32.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MARX Biotech Co (ROCO:7731) Overvalued in 2026?

Based on GuruFocus' analysis, MARX Biotech Co stock appears to be undervalued. The current stock price of NT$4.41 is trading 19.5% below its estimated GF Value™ of NT$5.48. GuruFocus considers MARX Biotech Co to be Modestly Undervalued.

Key valuation signals for ROCO:7731:

  • Beginning Cash Position: NT$32.8 Mil
  • GF Value™: NT$5.48 vs. price of NT$4.41 (19.5% below fair value)
  • GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the ROCO:7731 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MARX Biotech Co Business Description

Address 5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
38GF Score

Get the complete analysis for ROCO:7731

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$4.41
Price
NT$5.48
GF Value